Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
April 11, 2018
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
April 11, 2018
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
April 10, 2018
Improvements seen in mobility, body fat, muscle strength in men on androgen-deprivation therapy
Increasing burden of various diseases depending on state; overall death rates declined
Eight suggestions include providing individualized optimization training to personalize EHR settings
April 9, 2018
Majority say they want to know about even minor consequences of cancer drug substitutions
April 6, 2018
Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages
Cerebrospinal fluid biomarkers may identify those at greater risk for poor neuro-related outcomes
Findings based on eight-month evaluation of new interns using Fitbit activity trackers
April 5, 2018
Correlates of screening include older age, family history of melanoma or skin cancer, high SPF sunscreen use
A 69.3 percent difference was seen in HPV mRNA results compared with previous HPV DNA results
Enrollees have more chronic conditions, health care use versus other privately insured individuals
No difference in Press Ganey PSS for physicians with versus those without negative online reviews
April 4, 2018
However, more than half of all prescriber’s patient directions could be categorized into 25 concepts
Palpable cancers often detected at smaller size in breasts with implants; higher rates of mastectomy
HTN, increased LDL and total cholesterol levels; lower rates of decreased HDL levels, abdominal fat
April 2, 2018
Survey reveals ideas for more ‘robust involvement’ in undergraduate medical education
Up-front total, completion thyroidectomy rates fell after guidelines on thyroid CA surgery implemented
March 30, 2018
FOLFOX therapy for 6 months had higher disease-free survival rate compared to 3 months of treatment
Findings based on rates among women versus steady decline seen nationally
From 2010 to 2016, decrease seen each year in proportion of survivors reporting delayed medical care